Form 4: Apyx Medical COO Exercises 12,000 Stock Options

Apyx Medical's Chief Operating Officer, Shawn David Roman, exercised stock options to acquire 12,000 shares of common stock at $1.80 per share.

Summary

• Shawn David Roman, Chief Operating Officer of Apyx Medical Corp, exercised stock options on January 27, 2026.
• The transaction involved the acquisition of 12,000 shares of Apyx Medical Corp common stock.
• The exercise price for these shares was $1.80 per share.
• The shares were acquired pursuant to the Issuer's 2015 Share Incentive Plan.
• Following the transaction, 12,000 shares are beneficially owned indirectly by The Roman Family Revocable Trust, of which Mr. Roman is both a trustee and beneficiary.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal. While an option exercise is often a planned event, the COO's decision to acquire shares rather than sell them immediately suggests continued confidence in Apyx Medical's value.

Positives

• The exercise of stock options by a Chief Operating Officer can signal confidence in the company's future prospects, as the insider is increasing their equity stake.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and systematic approach to equity management.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the scheduled transaction date.

Industry Context

StockSavvy.ai notes that insider option exercises, especially when conducted under a Rule 10b5-1 plan, are a common component of executive compensation and equity management strategies. This specific transaction reflects a routine compensation event rather than a discretionary market timing move, aligning with typical practices for executives managing their long-term equity incentives.

Related Party Transactions

• The 12,000 shares acquired are held indirectly by The Roman Family Revocable Trust, of which the Reporting Person, Shawn David Roman, is both a trustee and beneficiary, constituting a related party transaction.

Stakeholder Impact

• Shareholders: The exercise of options results in a minor increase in outstanding shares, but also signals insider confidence.
• Chief Operating Officer (Shawn David Roman): Increases his direct and indirect equity stake in the company, aligning his interests further with shareholders.

Key Dates

Recommendation

The exercise of stock options by a key executive, particularly under a 10b5-1 plan, is generally a neutral to slightly positive event. It indicates the executive is taking action on their compensation and maintaining or increasing their equity exposure, which can be seen as a sign of confidence. However, it is not a strong enough signal on its own to warrant a 'buy' recommendation without further fundamental analysis of the company's performance and valuation. Therefore, a 'hold' recommendation is appropriate, suggesting investors monitor the company's broader financial health and strategic direction.

Keywords

Apyx Medical Corp, APYX, Shawn Roman, Chief Operating Officer, Stock Options, Insider Transaction, Form 4, Equity Acquisition, 10b5-1 Plan